
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.411522633745 | 2.43 | 2.52 | 2.33 | 91389 | 2.40930363 | CS |
4 | -0.185 | -7.10172744722 | 2.605 | 2.68 | 2.33 | 90425 | 2.45623786 | CS |
12 | -0.16 | -6.2015503876 | 2.58 | 2.73 | 2.33 | 183448 | 2.54413091 | CS |
26 | 0.57 | 30.8108108108 | 1.85 | 3 | 1.815 | 485568 | 2.44129483 | CS |
52 | -21.01 | -89.6713615023 | 23.43 | 32.415 | 1.25 | 571682 | 4.18928131 | CS |
156 | -6.91 | -74.0621650589 | 9.33 | 32.415 | 1.25 | 250050 | 7.64330395 | CS |
260 | -25.58 | -91.3571428571 | 28 | 32.415 | 1.25 | 223826 | 8.35054011 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions